BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 29976092)

  • 1. Helicobacter pylori drug resistance: therapy changes and challenges.
    Flores-Treviño S; Mendoza-Olazarán S; Bocanegra-Ibarias P; Maldonado-Garza HJ; Garza-González E
    Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):819-827. PubMed ID: 29976092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Helicobacter pylori-associated diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for the treatment of Helicobacter pylori infection.
    Shiota S; Yamaoka Y
    Curr Pharm Des; 2014; 20(28):4489-500. PubMed ID: 24180402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
    Liu Q; Qi D; Kang J; Jin Y; Liu W; Gao W; Hou P; Lu J
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):221-5. PubMed ID: 25629566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori - 2012].
    Buzás GM
    Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam.
    Phan TN; Tran VH; Tran TN; Le VA; Santona A; Rubino S; Paglietti B
    J Infect Dev Ctries; 2015 Jul; 9(6):609-13. PubMed ID: 26142670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
    Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
    Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
    Bilgilier C; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Dolak W; Makristathis A; Steininger C
    Ann Hematol; 2016 Jun; 95(7):1115-20. PubMed ID: 27091350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current options for the treatment of Helicobacter pylori.
    Georgopoulos SD; Papastergiou V; Karatapanis S
    Expert Opin Pharmacother; 2013 Feb; 14(2):211-23. PubMed ID: 23331077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone-based protocols for eradication of Helicobacter pylori.
    Rispo A; Capone P; Castiglione F; Pasquale L; Rea M; Caporaso N
    World J Gastroenterol; 2014 Jul; 20(27):8947-56. PubMed ID: 25083067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].
    Demiray E; Yilmaz O
    Mikrobiyol Bul; 2005 Jul; 39(3):399-408. PubMed ID: 16358500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications.
    Gerrits MM; van Vliet AH; Kuipers EJ; Kusters JG
    Lancet Infect Dis; 2006 Nov; 6(11):699-709. PubMed ID: 17067919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide H. pylori antibiotic resistance: a systematic review.
    De Francesco V; Giorgio F; Hassan C; Manes G; Vannella L; Panella C; Ierardi E; Zullo A
    J Gastrointestin Liver Dis; 2010 Dec; 19(4):409-14. PubMed ID: 21188333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland.
    O'connor A; Taneike I; Nami A; Fitzgerald N; Murphy P; Ryan B; O'connor H; Qasim A; Breslin N; O'moráin C
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1123-7. PubMed ID: 20354442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.
    Lee JW; Kim N; Kim JM; Nam RH; Chang H; Kim JY; Shin CM; Park YS; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):206-14. PubMed ID: 23241101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Helicobacter pylori.
    Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
    Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.
    Smith SM; O'Morain C; McNamara D
    World J Gastroenterol; 2014 Aug; 20(29):9912-21. PubMed ID: 25110421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial effectiveness of furazolidone against metronidazole-resistant strains of Helicobacter pylori.
    Safaralizadeh R; Siavoshi F; Malekzadeh R; Akbari MR; Derakhshan MH; Sohrabi MR; Massarrat S
    East Mediterr Health J; 2006; 12(3-4):286-93. PubMed ID: 17037696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.